About this Research Topic
Diabetes mellitus is a chronic heterogeneous disease characterized by an altered metabolism of glucose and other energy substrates and by the development of vascular and neuropathic complications. This disease cannot be cured, and therefore, it is advisable to know the mechanisms that relate diabetes to other metabolic disorders and the targeted clinical and laboratory approaches to manage the cardiovascular risk, which could create a severe deterioration of the patient's state of health.
The goal of this Research Topic is to bring together a collection of papers on cutting-edge research and insights into the mechanisms that bind several dysmetabolisms with type 2 diabetes mellitus, the biomarkers and/or innovative therapeutic approaches necessary for the integrated management of this disabling pathology and the comorbidities associated.
We welcome the submission of manuscripts including, but not limited to, the following topics:
• Type 2 diabetes mellitus:
- associated dysmetabolisms (obesity; dyslipidaemia; hypertension; Metabolic Associated Fatty Liver Disease, MAFLD).
- mechanisms that determine cardiometabolic risk with particular attention to inflammatory, oxidative processes and endothelial alterations.
- laboratory management with identification of biomarkers useful in diagnosis, prognosis, and therapy monitoring.
- pharmacological and nutraceutical approaches for the integrated management of this chronic pathology.
Submissions from researchers and clinicians in endocrinology, internist, biochemistry, neurologist, and related disciplines are encouraged.
Original research papers and state-of-the-art reviews will be considered.
The goal of this Research Topic is to bring together a collection of papers on cutting-edge research and insights into the mechanisms that bind several dysmetabolisms with type 2 diabetes mellitus, the biomarkers and/or innovative therapeutic approaches necessary for the integrated management of this disabling pathology and the comorbidities associated.
We welcome the submission of manuscripts including, but not limited to, the following topics:
• Type 2 diabetes mellitus:
- associated dysmetabolisms (obesity; dyslipidaemia; hypertension; Metabolic Associated Fatty Liver Disease, MAFLD).
- mechanisms that determine cardiometabolic risk with particular attention to inflammatory, oxidative processes and endothelial alterations.
- laboratory management with identification of biomarkers useful in diagnosis, prognosis, and therapy monitoring.
- pharmacological and nutraceutical approaches for the integrated management of this chronic pathology.
Submissions from researchers and clinicians in endocrinology, internist, biochemistry, neurologist, and related disciplines are encouraged.
Original research papers and state-of-the-art reviews will be considered.
Keywords: type 2 diabetes mellitus; diabetes complications; obesity; dyslipidaemia; insulin resistance; inflammation; oxidative stress; metabolic disorders; neurodegenerative alterations; molecular biomarkers
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
